UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall ?

Thrombosis research, 1990-11, Vol.60 (3), p.231-236

1990

Volltextzugriff (PDF)

Laboratory Control of Heparin and Heparin Fragment Treatment: An Experimental Study

Seminars in thrombosis and hemostasis, 1989-10, Vol.15 (4), p.373-377

1989

Volltextzugriff (PDF)

Could thrombus age be a modulator of heparin or L.M.W.H activities ?

Thrombosis research, 1989-08, Vol.55 (4), p.407-417

1989

Volltextzugriff (PDF)

Aspirin at very ultra low dosage in healthy volunteers: effects on bleeding time, platelet aggregation and coagulation

Haemostasis, 1990-01, Vol.20 (2), p.99

1990

Volltextzugriff (PDF)

In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages

Thrombosis research, 1992, Vol.65 (1), p.33-43

1992

Volltextzugriff (PDF)

Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model

Journal of leukocyte biology, 1987-12, Vol.42 (6), p.628-631

1987

Volltextzugriff (PDF)

Template bleeding time after ingestion of ultra low dosages of acetyl salicylic acid in healthy subjects. Preliminary study

Thrombosis research, 1987-11, Vol.48 (4), p.501-504

1987

Volltextzugriff (PDF)

The tPA-like activity induced by heparin and a heparin fragment binds on experimental thrombus

Thrombosis research, 1988-04, Vol.50 (2), p.335-338

1988

Volltextzugriff (PDF)

Platelet aggregation on whole blood after administration of ultra low dosage acetylsalicylic acid in healthy volunteers

Thrombosis research, 1987-08, Vol.47 (3), p.373-377

1987

Volltextzugriff (PDF)

What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?

Thrombosis research, 1987-10, Vol.48 (2), p.245-251

1987

Volltextzugriff (PDF)

How to standardize low molecular weight heparins

Annales de biologie clinique (Paris), 1990, Vol.48 (4), p.221

1990

Volltextzugriff (PDF)

Potentiation by heparins of the action of leukocytes in experimental venous thrombosis

Annales pharmaceutiques françaises, 1988, Vol.46 (3), p.197

1988

Volltextzugriff (PDF)

Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. In vitro and in vivo study

Therapie, 1986-11, Vol.41 (6), p.433

1986

Volltextzugriff (PDF)

Could proteolytic enzyme modulate the interaction platelets/vessel wall in presence of asa at ultra low doses?

Thrombosis research, 1991-08, Vol.63 (4), p.419-426

1991

Volltextzugriff (PDF)

Role of bone marrow in the development of thrombosis. A study of the curative and prophylactic action of heparin and heparin fragment (CY 222)

Thrombosis research, 1989-05, Vol.54 (4), p.369-375

1989

Volltextzugriff (PDF)

Thrombogenic properties of ultra-low-dose of acetylsalicylic acid in a vessel model of laser-induced thrombus formation

Thrombosis research, 1994-10, Vol.76 (2), p.225-229

1994

Volltextzugriff (PDF)

Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases

Brain (London, England : 1878), 2009-08, Vol.132 (8), p.2161-2169

2009

Volltextzugriff (PDF)

Protamine neutralization of a very low molecular weight heparin fragment CY 222 in vitro and in vivo study

Thrombosis research, 1986, Vol.41, p.88-88

1986

Volltextzugriff (PDF)

Intermittent catheterization: Clinical practice guidelines from Association Française d’Urologie (AFU), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)

Progrès en urologie (Paris), 2020-04, Vol.30 (5), p.232-251

2020

Volltextzugriff (PDF)

Low-molecular weight heparins in post-surgical recovery

Annales de biologie clinique (Paris), 1988, Vol.46 (3), p.190

1988

Volltextzugriff (PDF)

Variation of bleeding time after administration of acetyl salicylic acid at different doses in the healthy volunteer

Annales pharmaceutiques françaises, 1988, Vol.46 (1), p.35

1988

Volltextzugriff (PDF)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

Journal of neuroinflammation, 2018-05, Vol.15 (1), p.134-134, Article 134

2018

Volltextzugriff (PDF)

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

European journal of neurology, 2014-01, Vol.21 (1), p.40-48

2014

Volltextzugriff (PDF)

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

Multiple sclerosis, 2023-02, Vol.29 (2), p.236-247

2023

Volltextzugriff (PDF)

Low molecular weight heparins

Annales pharmaceutiques françaises, 1989, Vol.47 (3), p.109

1989

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(290)
Mit Volltextzugriff
(266)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall ?

Laboratory Control of Heparin and Heparin Fragment Treatment: An Experimental Study

Could thrombus age be a modulator of heparin or L.M.W.H activities ?

Aspirin at very ultra low dosage in healthy volunteers: effects on bleeding time, platelet aggregation and coagulation

In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages

Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model

Template bleeding time after ingestion of ultra low dosages of acetyl salicylic acid in healthy subjects. Preliminary study

The tPA-like activity induced by heparin and a heparin fragment binds on experimental thrombus

Platelet aggregation on whole blood after administration of ultra low dosage acetylsalicylic acid in healthy volunteers

What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?

How to standardize low molecular weight heparins

Potentiation by heparins of the action of leukocytes in experimental venous thrombosis

Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. In vitro and in vivo study

Could proteolytic enzyme modulate the interaction platelets/vessel wall in presence of asa at ultra low doses?

Role of bone marrow in the development of thrombosis. A study of the curative and prophylactic action of heparin and heparin fragment (CY 222)

Thrombogenic properties of ultra-low-dose of acetylsalicylic acid in a vessel model of laser-induced thrombus formation

Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases

Protamine neutralization of a very low molecular weight heparin fragment CY 222 in vitro and in vivo study

Low-molecular weight heparins in post-surgical recovery

Variation of bleeding time after administration of acetyl salicylic acid at different doses in the healthy volunteer

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

Low molecular weight heparins

Suchergebnisse filtern